NDC product
Norepinephrine bitartrate
NDC 36000-162 · Baxter Healthcare Corporation
Key facts
| Product NDC | 36000-162 |
|---|---|
| Proprietary name | Norepinephrine bitartrate |
| Labeler | Baxter Healthcare Corporation |
| Marketing category | ANDA |
| Application number | ANDA040859 |
| Marketing start | Apr 1, 2012 |
| Marketing end | Apr 29, 2026 |
| Listing certified through | Apr 29, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: